Evaluation of the NucliSens EasyQ v2.0 Assay in Comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in Quantification of C-Clade HIV-1 in Plasma

• Maximilian Muenchhoff,

  Affiliations Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

  ⨯
• Savathee Madurai,

  Affiliation Global Clinical and Viral Laboratories, Amanzimtoti, KwaZulu-Natal, South Africa

  ⨯
• Allison Jo Hempenstall,

  Affiliation Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom

  ⨯
• Emily Adland,

  Affiliation Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom

  ⨯
• Anna Carlqvist,

  Affiliation Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom

  ⨯
• Angeline Moonsamy,

  Affiliation HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

  ⨯
• Manjeetha Jaggernath,

  Affiliation HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

  ⨯
• Busisiwe Mlotshwa,

  Affiliation HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

  ⨯
• Emma Siboto,

  Affiliation HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

  ⨯
• Thumbi Ndung'u,

  Affiliations HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), University of KwaZulu-Natal, Durban, South Africa, Max Planck Institute for Infection Biology, Berlin, Berlin, Germany, The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, United States of America

  ⨯
• Philip Jeremy Renshaw Goulder

  * E-mail: philip.goulder@paediatrics.ox.ac.uk

  Affiliations Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa, The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, United States of America

  ⨯